Beauty Farm Medical and Health Industry Inc. (HKG:2373)
Hong Kong · Delayed Price · Currency is HKD 18.20
-0.31 (-1.67%)
Sep 2, 2026, 4:08 PM HKT
HKG:2373 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,517 | 6,388 | 4,197 | 2,613 | - | - | |
Market Cap Growth | -45.40% | 52.20% | 60.65% | - | - | - |
Enterprise Value | 3,330 | 5,106 | 3,205 | 1,624 | - | - |
Last Close Price | 18.20 | 26.18 | 16.86 | 10.19 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.82 | 18.08 | 17.26 | 11.00 | - | - |
Forward PE | 8.47 | 16.51 | 13.66 | 7.50 | - | - |
PS Ratio | 1.14 | 1.91 | 1.53 | 1.11 | - | - |
PB Ratio | 2.67 | 5.38 | 4.04 | 2.84 | - | - |
P/TBV Ratio | - | - | - | 4.70 | - | - |
P/FCF Ratio | 3.65 | 6.16 | 5.78 | 5.09 | - | - |
P/OCF Ratio | 3.43 | 5.75 | 4.95 | 3.79 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.84 | 1.53 | 1.17 | 0.69 | - | - |
EV/EBITDA Ratio | 2.87 | 7.60 | 6.69 | 3.82 | - | - |
EV/EBIT Ratio | 5.13 | 10.15 | 9.74 | 5.48 | - | - |
EV/FCF Ratio | 2.69 | 4.92 | 4.41 | 3.16 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.90 | 1.21 | 0.75 | 0.68 | 2.59 | 1.96 |
Debt / EBITDA Ratio | 1.31 | 1.52 | 1.06 | 0.94 | 1.22 | 0.97 |
Debt / FCF Ratio | 1.23 | 1.39 | 1.07 | 1.21 | 2.18 | 0.96 |
Net Debt / Equity Ratio | -0.74 | -1.17 | -1.13 | -1.21 | -1.90 | -2.16 |
Net Debt / EBITDA Ratio | -1.44 | -2.07 | -2.44 | -2.62 | -1.59 | -1.59 |
Net Debt / FCF Ratio | -1.01 | -1.34 | -1.61 | -2.17 | -1.60 | -1.06 |
Asset Turnover | 0.64 | 0.64 | 0.68 | 0.74 | 0.66 | 0.78 |
Inventory Turnover | 7.91 | 8.43 | 6.30 | 5.61 | 5.75 | 8.30 |
Quick Ratio | 0.66 | 0.90 | 0.70 | 0.81 | 0.52 | 0.61 |
Current Ratio | 0.75 | 0.98 | 0.80 | 0.94 | 0.65 | 0.71 |
Return on Equity (ROE) | 34.13% | 33.32% | 27.91% | 44.37% | 47.48% | 103.33% |
Return on Assets (ROA) | 6.54% | 6.06% | 5.10% | 5.80% | 3.41% | 7.03% |
Return on Capital Employed (ROCE) | 21.50% | 21.10% | 20.10% | 21.50% | 23.20% | 41.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.82% | 5.53% | 5.79% | 9.09% | - | - |
FCF Yield | 27.43% | 16.24% | 17.30% | 19.66% | - | - |
Dividend Yield | 4.04% | 2.68% | 3.08% | 4.61% | - | - |
Payout Ratio | 31.84% | 38.50% | 49.24% | 40.34% | 198.10% | 41.95% |
Buyback Yield / Dilution | -3.96% | -0.92% | 0.14% | -14.99% | -0.24% | - |
Total Shareholder Return | 0.08% | 1.76% | 3.23% | -10.38% | -0.24% | - |